Drug side effects

August 26, 2007

A recent survey by Beatrice Golomb and her colleagues which was reported by Reuters Health discovered that when patients reported adverse reactions to drugs their doctors routinely denied that the drug was responsible for these side effects. To a great extent this is due to doctors’ lack of knowledge about potential side effects, but I suspect it is also because doctors have an unreasonable degree of reliance and faith in drugs. Pharmaceutical companies are doing a great job selling benefits of drugs to doctors, but the education about potential side effects is clearly lacking. Medical school training also makes doctors biased toward drugs and against alternative therapies. In treating migraine patients I often see people who were prescribed by their doctor 2-3 daily medications and who were never offered any alternatives. The efficacy of many of the supplements (magnesium, CoQ10, alpha-lipoic acid and others) is as good as that of many drugs doctors use for headaches. Eliminating caffeine, regular exercise, dietary changes, biofeedback and even Botox injections are some of the other excellent approaches that should be tried before drugs.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe